Stock listing
NASDAQ:JSPR Jasper Therapeutics, Inc. Stock
Home listing (NASDAQ) of Jasper Therapeutics, Inc.
Follow Jasper Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:JSPR
$0.52 USD -0.01 (-2.2%)
Close on Oct 30, 2026
- Day range
- $0.511 – $0.554 USDOct 30, 2026
- Volume
- 396,005 sharesOct 30, 2026
- Market cap
- $17.31M USDAt the close on Oct 30, 2026 · price × 33.27M shares outstanding
- 52-week range
- $0.315 – $2.42 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $327,779 USDMedian day 378,000 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:JSPR · Home | $0.52 USD | -0.012 (-2.2%) | 396,005 | $0.516 | $0.554 | $0.511 | $0.532 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:JSPR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.52 | -0.012 | -2.2% | $0.516 | $0.554 | $0.511 | 396,005 | |
| $0.532 | -0.007 | -1.3% | $0.533 | $0.563 | $0.511 | 413,078 | |
| $0.539 | +0.02 | +3.8% | $0.50 | $0.548 | $0.50 | 371,170 | |
| $0.519 | +0.014 | +2.7% | $0.477 | $0.53 | $0.464 | 1,324,168 | |
| $0.505 | -0.005 | -0.9% | $0.51 | $0.521 | $0.495 | 396,738 | |
| $0.51 | +0.014 | +2.8% | $0.49 | $0.54 | $0.484 | 323,543 | |
| $0.496 | -0.008 | -1.6% | $0.50 | $0.515 | $0.49 | 72,300 | |
| $0.504 | +0.004 | +0.8% | $0.52 | $0.54 | $0.497 | 358,800 | |
| $0.50 | +0.023 | +4.8% | $0.478 | $0.529 | $0.477 | 366,500 | |
| $0.477 | -0.003 | -0.6% | $0.47 | $0.49 | $0.46 | 391,500 | |
| $0.48 | -0.052 | -9.8% | $0.546 | $0.55 | $0.478 | 245,600 | |
| $0.532 | +0.031 | +6.2% | $0.49 | $0.545 | $0.476 | 380,000 | |
| $0.501 | +0.005 | +1.0% | $0.501 | $0.517 | $0.46 | 620,100 | |
| $0.496 | -0.059 | -10.6% | $0.54 | $0.54 | $0.496 | 429,300 | |
| $0.555 | -0.015 | -2.6% | $0.569 | $0.577 | $0.545 | 335,800 | |
| $0.57 | +0.01 | +1.8% | $0.547 | $0.577 | $0.541 | 261,900 | |
| $0.56 | -0.01 | -1.8% | $0.563 | $0.58 | $0.54 | 362,200 | |
| $0.57 | +0.01 | +1.8% | $0.543 | $0.59 | $0.54 | 365,200 | |
| $0.56 | -0.033 | -5.6% | $0.60 | $0.60 | $0.55 | 327,900 | |
| $0.593 | +0.028 | +5.0% | $0.57 | $0.596 | $0.542 | 376,000 | |
| $0.565 | -0.033 | -5.5% | $0.60 | $0.615 | $0.563 | 236,100 | |
| $0.598 | +0.018 | +3.1% | $0.59 | $0.64 | $0.585 | 294,600 | |
| $0.58 | -0.045 | -7.2% | $0.62 | $0.655 | $0.572 | 538,500 | |
| $0.625 | -0.001 | -0.2% | $0.642 | $0.675 | $0.584 | 915,700 | |
| $0.626 | +0.017 | +2.8% | $0.606 | $0.656 | $0.60 | 251,100 | |
| $0.609 | +0.024 | +4.1% | $0.593 | $0.62 | $0.579 | 163,100 | |
| $0.585 | +0.018 | +3.2% | $0.592 | $0.592 | $0.544 | 634,200 | |
| $0.567 | -0.056 | -9.0% | $0.628 | $0.648 | $0.567 | 427,000 | |
| $0.623 | +0.02 | +3.3% | $0.629 | $0.651 | $0.606 | 310,100 | |
| $0.603 | -0.015 | -2.4% | $0.636 | $0.67 | $0.60 | 206,000 | |
| $0.618 | -0.016 | -2.5% | $0.63 | $0.65 | $0.60 | 222,800 | |
| $0.634 | +0.053 | +9.1% | $0.59 | $0.66 | $0.59 | 303,600 | |
| $0.581 | +0.011 | +1.9% | $0.577 | $0.609 | $0.56 | 505,300 | |
| $0.57 | -0.063 | -10.0% | $0.64 | $0.644 | $0.568 | 402,600 | |
| $0.633 | -0.027 | -4.1% | $0.66 | $0.668 | $0.60 | 404,300 | |
| $0.66 | -0.041 | -5.8% | $0.693 | $0.711 | $0.66 | 294,300 | |
| $0.701 | 0.00 | 0.0% | $0.69 | $0.73 | $0.69 | 207,900 | |
| $0.701 | -0.008 | -1.1% | $0.701 | $0.714 | $0.68 | 60,300 | |
| $0.709 | 0.00 | 0.0% | $0.739 | $0.74 | $0.695 | 189,900 | |
| $0.709 | +0.023 | +3.4% | $0.67 | $0.71 | $0.664 | 432,800 | |
| $0.686 | -0.019 | -2.7% | $0.693 | $0.71 | $0.653 | 364,000 | |
| $0.705 | +0.007 | +1.0% | $0.688 | $0.72 | $0.68 | 380,300 | |
| $0.698 | -0.013 | -1.8% | $0.70 | $0.711 | $0.635 | 854,200 | |
| $0.711 | +0.011 | +1.6% | $0.715 | $0.74 | $0.655 | 388,000 | |
| $0.70 | +0.001 | +0.1% | $0.71 | $0.71 | $0.66 | 267,400 | |
| $0.699 | -0.019 | -2.6% | $0.707 | $0.744 | $0.69 | 254,200 | |
| $0.718 | -0.002 | -0.3% | $0.714 | $0.721 | $0.692 | 246,100 | |
| $0.72 | -0.002 | -0.3% | $0.709 | $0.74 | $0.699 | 271,500 | |
| $0.722 | +0.006 | +0.8% | $0.73 | $0.735 | $0.674 | 354,100 | |
| $0.716 | +0.025 | +3.6% | $0.68 | $0.736 | $0.675 | 780,800 | |
| $0.691 | -0.056 | -7.5% | $0.735 | $0.76 | $0.678 | 2,336,100 | |
| $0.747 | -0.003 | -0.4% | $0.744 | $0.81 | $0.72 | 294,300 | |
| $0.75 | -0.092 | -10.9% | $0.82 | $0.91 | $0.66 | 1,997,300 | |
| $0.842 | +0.052 | +6.6% | $0.77 | $0.916 | $0.746 | 798,800 | |
| $0.79 | -0.073 | -8.5% | $0.871 | $0.871 | $0.777 | 569,500 | |
| $0.863 | +0.039 | +4.7% | $0.811 | $0.943 | $0.806 | 992,300 | |
| $0.824 | -0.069 | -7.7% | $0.911 | $0.923 | $0.801 | 653,400 | |
| $0.893 | +0.094 | +11.8% | $0.818 | $0.97 | $0.80 | 1,433,700 | |
| $0.799 | +0.089 | +12.5% | $0.75 | $0.82 | $0.716 | 613,200 | |
| $0.71 | +0.064 | +9.9% | $0.652 | $0.75 | $0.65 | 760,600 | |
| $0.646 | -0.014 | -2.1% | $0.64 | $0.72 | $0.63 | 650,900 | |
| $0.66 | -0.006 | -0.9% | $0.666 | $0.668 | $0.61 | 336,000 | |
| $0.666 | +0.06 | +9.9% | $0.61 | $0.689 | $0.59 | 718,800 | |
| $0.606 | -0.024 | -3.8% | $0.63 | $0.64 | $0.593 | 322,100 | |
| $0.63 | +0.009 | +1.4% | $0.63 | $0.635 | $0.55 | 523,800 | |
| $0.621 | +0.021 | +3.5% | $0.60 | $0.641 | $0.581 | 499,000 |
- Ticker
- NASDAQ:JSPR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 15, 2026
Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 29 slides
Latest news
Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
Oct 15, 2026
Closed $0.532 (+6.2%) on Oct 15, 2026
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
Oct 7, 2026
Closed $0.57 (+1.8%) on Oct 7, 2026
Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
Sep 15, 2026
Closed $0.581 (+1.9%) on Sep 16, 2026
Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 9, 2026
Closed $0.701 (-1.1%) on Sep 9, 2026
Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 17, 2026
Closed $0.842 (+6.6%) on Aug 17, 2026
Jasper Therapeutics Announces Merger with Kira Pharmaceuticals
Jul 16, 2026
Closed $0.885 (+14.3%) on Jul 17, 2026
Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
Jun 1, 2026
Closed $0.534 (-35.6%) on Jun 1, 2026
Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026
Closed $0.85 (-11.4%) on May 15, 2026
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
Mar 30, 2026
Closed $0.90 (-14.3%) on Mar 30, 2026
Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference
Feb 24, 2026
Closed $1.40 (+1.4%) on Feb 25, 2026
Financings
Private placement of non-voting convertible preferred stock
Aug 17, 2026
Closed: US$132M raised · Piper Sandler & Co. +1
Dealers: Piper Sandler & Co. (lead), LifeSci Capital LLC (co-lead)
Buyers: Affinity Asset Advisors, LLC (co-led the private placement); Ikarian Capital LLC (co-led the private placement); Columbia Threadneedle Investments; Sirenia Capital Management LP; Brahma Capital; Balyasny Asset Management; SilverArc Capital; Squadron Capital Management; Nazare Partners LP; Mirador Therapeutics
Use of proceeds: Fund development of the combined company's pipeline through the second half of 2028
Decks
Investor Presentation (September 2026)
Investor deck · 29 slides · September 2026
Merger or Acquisition (July 2026)
Merger or acquisition · 30 slides · Jul 17, 2026
JPM TMT Conference (January 2026)
Conference · 14 slides · Jan 8, 2026
Corporate Update (January 2026)
Corporate update · 20 slides · Jan 8, 2026
Jasper Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 94 in all · newest Oct 15, 2026 · oldest 2021
- Decks
- 22 decks · latest September 2026
Where Jasper Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:JSPR · Home listing · This page | NASDAQ | United States | USD |
| BOATS:JSPR | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Jasper Therapeutics, Inc.